Jan 20, 2026
Which specific FDA warning letters name compounding pharmacies that marketed compounded tirzepatide, and what violations were cited?
The FDA issued warning letters in September 2025 that explicitly name multiple online sellers and compounding pharmacies marketing compounded tirzepatide, including GLP‑1 Solution and Healthy Male, an...